S. Thierfelder

Even With Minute Cerebrospinal Fluid Cell Specimens
20170 citationsauthor #3
C3-decomplemented mice differentiates two T-cell-depletion pathways Antibody- induced suppression of graft-versus-host disease in Antilymphocytic antibodies and marrow transplantation. XIV.
20110 citationsauthor #1
Growth of the Reh cell line in diffusion chambers. Evidence for differentiation along the T- and B-cell pathway.
200924 citationsauthor #9
Immunosuppression of the donor in order to affect chronic secondary disease of the recipient
20053 citationsauthor #1
Experimental bone marrow transplantation
20052 citationsauthor #1
Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12
20052 citationsauthor #4
ABO Rh blood groups and platelet transfusion
20057 citationsauthor #2
In-vitro induction of some features of hairy cell leukemia in chronic lymphocytic leukemia and immunocytoma cells
20040 citationsauthor #5
B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity
200013 citationsauthor #4
Analysis of peripheral immune tolerance uncovers a mouse strain‐dependent in situ type of graft tolerance
19994 citationsauthor #2
Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype
199913 citationsauthor #11
Long‐lasting unresponsiveness to polyclonal T cell‐binding immunoglobulins
19981 citationsauthor #2
Idiotype vaccination against B cell lymphoma requires injection of gene-modified tumor cells
19970 citationsauthor #3
IMMUNOTHERAPY MEDICAMENTS CONTAINING ANTIBODIES WHICH SPECIFICALLY DETECT THE MHCII ANTIGEN OF A PATIENT TO BE TREATED
19970 citationsauthor #2
Mitogenicity of anti-TCR/CD3 mAbs attributable to ineffective cross-linking of low-affinity Fc-γ receptors
19970 citationsauthor #5
The destruction of contaminating tumor cells in stem cell with bispecific antibodies
19970 citationsauthor #4
Cytokine gene transfer studies in a murine B cell lymphoma model
19970 citationsauthor #4
Induction and suppression of anti‐antibodies to syngeneic T cell‐binding antibodies in mice
19976 citationsauthor #3
Preclinical evaluation of biotin labeling for red cell survival testing
199717 citationsauthor #10
Using bi- and trispecific antibodies for the induction of tumor immunity
19970 citationsauthor #3
Retinoid regulation of interleukin-2 receptors on human T-cells.
199724 citationsauthor #4
Destroying contaminating tumor cells in stem cell transplants with bispecific antibodies
19960 citationsauthor #4
Drugs for immunotherapy, containing antibodies which specifically recognize the MHCII-antigen of a patient to be treated
19950 citationsauthor #2
Immunosuppression by Fc region‐mismatched anti‐T cell antibody treatment
199510 citationsauthor #1
Unaltered immunoglobulin expression in hybridoma cells modified by targeting of the heavy chain locus with an integration vector.
19957 citationsauthor #5
Suppression of normal and neoplastic human T cells with unconjugated monoclonal antibodies in SCID mouse chimeras.
19953 citationsauthor #4
Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies.
1995212 citationsauthor #4
Immunological approach to inhibit formation of anti‐antibodies to allo‐ and xenogeneic anti‐T cell immunoglobulin
19943 citationsauthor #2
Use of antibodies to T cells for prolonged immunosuppression
19940 citationsauthor #1
Single as well as pairs of synergistic anti-CD4+CD8 antibodies prevent graft-versus-host disease in fully mismatched mice.
199417 citationsauthor #3
A mouse model for the preclinical evaluation of immunosuppressive effector functions of human isotypes. The human IgG1 isotype is superior to IgG3.
19948 citationsauthor #4
Drugs for the treatment of immune responses
19930 citationsauthor #2
Mitogenicity of anti‐Thy‐1 monoclonal antibodies attributable to an Fc‐dependent mechanism
19933 citationsauthor #5
Coinjection of anti-interleukin-2 receptor antibody diminishes antiantibody formation during prolonged treatment with anti-CD3 antibody.
19930 citationsauthor #2
Optimized detection of cytoplasmic immunoglobulin and CD3 in benign and malignant lymphoid cells: enhanced sensitivity combined with differential staining of endogenous peroxidases and light microscopic morphology.
19937 citationsauthor #2
Antigen binding and effector functions of a chimeric antibody with a deletion of the CH1 domain and non-covalently associated kappa chains.
19932 citationsauthor #4
Murine anti‐mouse T cell monoclonal antibodies elicit anti‐antibodies in mice: intra‐species immunization model for estimating potential patient sensitization against humanized anti‐T cell antibodies
19936 citationsauthor #4
Hybridoma cells which produce antibodies that are contained as an active ingredient in medicaments for the treatment of immune responses
19930 citationsauthor #2
Antibody-induced suppression of graft versus host disease, animal models
19930 citationsauthor #1
An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
19933 citationsauthor #4
Biotin labeling as an alternative nonradioactive approach to determination of red cell survival
199350 citationsauthor #7
Determination of monoclonal antibody specificity by immunoadsorption and western blotting.
199215 citationsauthor #5
Cerebrospinal fluid immunocytology in primary central nervous system lymphoma.
19929 citationsauthor #2
Immunohistochemical localisation of monoclonal antibody R 24-recognized ganglioside Glac2 in early chick embryos.
19925 citationsauthor #1
Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein‐Barr virus‐negative donors
199246 citationsauthor #4
Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.
199211 citationsauthor #2
Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies
199135 citationsauthor #7
Glycosphingolipids in embryogenesis : biosynthesis and localization of forssman-glycolipid and ganglioside Glac2 in early chick embryos
19910 citationsauthor #1
ANTILYMPHOCYTIC ANTIBODIES AND BONE MARROW TRANSPLANTATION
19900 citationsauthor #2
Antigen density on target cells determines the immunosuppressive potential of rat IgG2b monoclonal antibodies
199018 citationsauthor #2
Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
19907 citationsauthor #2
NEUTRALIZATION OF IMMUNOSUPPRESSION BY ANTIBODIES AGAINST VARIABLE AS WELL AS CONSTANT REGIONS OF MONOCLONAL ANTI‐THY-1 XENOANTIBODIES AND THEIR ABILITY TO BE SUPPRESSED BY INITIAL T CELL DEPLETION
198922 citationsauthor #2
Immunocytochemical identification of meningeal leukemia and lymphoma: poly-L-lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens.
198944 citationsauthor #3
Antilymphocytic antibodies and marrow transplantation. IX. T-cell depletion in marrow donors with C1q high and low affinity antibodies for suppression of GVHD in fully mismatched mice.
19894 citationsauthor #3
Anti-Thy-1 in bone marrow transplantation.
19890 citationsauthor #1
Antilymphocytic antibodies and marrow transplantation: ATG suppresses antiantibody formation against monoclonal anti-T-cell antibodies.
19890 citationsauthor #1
RECOGNITION OF TWO EPITOPES OF AN ANTIGEN PRESENT ON CANINE T CELLS BUT NOT ON HEMOPOIETIC PROGENITORS BY FOUR MONOCLONAL ANTIBODIES
198810 citationsauthor #3
Lymphocyte surface markers profile in acute lymphoblastic leukaemia.
19870 citationsauthor #6
Transplantation tolerance following conditioning with C1q-affinity anti-Thy-1 monoclonal antibodies.
19870 citationsauthor #1
In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
198716 citationsauthor #2
Effective avidin coating of erythrocytes by disulfide bond formation. Production of a stable rosetting agent for multiple applications.
19867 citationsauthor #2
Prognostic significance of adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies
19860 citationsauthor #6
Combined prophylactic suppression of graft-versus-host and host-versus-graft reactions following treatment of prospective bone marrow recipients with rat IgG2b anti-mouse T cell antibodies
19860 citationsauthor #1
Simultaneous demonstration of two antigens on single T cells using antibodies with contrasting labels.
19867 citationsauthor #6
Improved detection of terminal transferase (TdT): the use of detergents on glutaraldehyde-fixed non-dehydrated cells prevents denaturation and diffusion artifacts.
198630 citationsauthor #2
Antilymphocytic antibodies and marrow transplantation. VIII. Recipient conditioning with Clq-affine monoclonal anti-pan T antibodies prevents GVHD in homozygous fully mismatched mice.
198615 citationsauthor #1
INVITRO TREATMENT OF MARROW WITH ATCG OR CAMPATH-1 FOR PROPHYLAXIS OF GVHD - RESULTS OF THE AG-KMT MUNCHEN
19853 citationsauthor #9
Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
198517 citationsauthor #1
In vitro Treatment of Marrow with ATCG or Campath-1 for Prophylaxis of GVHD
19853 citationsauthor #9
Quantitation of antibody uptake on a group erythrocytes using immunoautoradiography and monoclonal IgM anti-A
19852 citationsauthor #4
INFLUENCE OF ISOTYPE ON SUPPRESSION OF GVH WITH ANTI-TH-1
19843 citationsauthor #1
Autologous Bone Marrow Transplantation m Leukemia
19840 citationsauthor #3
Treatment of Autologous Bone Marrow Grafts with Antibodies Against All Cells
19841 citationsauthor #1
[Lymphocyte markers in sarcoidosis and tuberculosis].
19840 citationsauthor #5
Autologous bone marrow transplantation in leukemia.
19849 citationsauthor #3
Serological inhibition of graft versus host disease: recent results in 28 patients with leukemia.
19832 citationsauthor #2
Crossreaction of monoclonal Anti-T-cell antibodies: Implications for classifying B-cell leukemias
19832 citationsauthor #5
Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
198320 citationsauthor #2
Surprizing differences in immunosuppression by various monoclonal anti-th-1. Abstr.
19830 citationsauthor #1
ANTILYMPHOCYTIC ANTIBODIES AND MARROW TRANSPLANTATION: VI ABSENCE OF IMMUNOSUPPRESSION IN VIVO AFTER INJECTION OF MONOCLONAL ANTIBODIES BLOCKING GRAFT‐VERSUS-HOST REACTIONS AND HUMORAL ANTIBODY FORMATION IN VITRO
19837 citationsauthor #1
Analysis with monoclonal antibodies of human lymphoid cells forming rosettes with rabbit red blood cells.
198314 citationsauthor #4
Effect of monoclonal antibodies on gvhd in minor and mhc-incompatible mouse models.
19831 citationsauthor #2
Immunofluorescence with monoclonal antibodies on poly-L-lysine coated slides: an alternative to conventional methods
19833 citationsauthor #5
Auer-rod positive myelocytic leukemia cells in diffusion chambers: Differentiation along the eosinophilic pathway
19820 citationsauthor #5
Comparison of currently available monoclonal antibodies with conventional markers for phenotyping of one hundred acute leukemias
19826 citationsauthor #8
Characterization of autologous rosette-forming cells with a series of monoclonal antibodies.
19820 citationsauthor #3
Monoclonal antibodies against T-cell antigens studied by immunohistochemistry
19821 citationsauthor #8
Anatomical distribution of call antigen expressing cells in normal lymphatic tissue and in lymphomas.
198236 citationsauthor #3
Tritium radiolabeling of antibodies to high specific activity with N-succinimidyl [2,3-3H] propionate: use in detecting monoclonal antibodies.
198131 citationsauthor #6
Patterns of Cell Surface Differentiation of cALL Positive Leukemic Blast Cells in Diffusion Chamber Culture
19810 citationsauthor #6
Immunohistochemical identification of T- and B-lymphocytes delineated by the unlabelled antibody enzyme method
19818 citationsauthor #4
The concept of GvHD-suppression by in vitro treatment with antisera.
19811 citationsauthor #2
Differential expression of t- and b-markers on akr/j lymphomas. Abstr.
19810 citationsauthor #2
Suppressive activity of cell-free ascites obtained from murine tumors
19813 citationsauthor #3
[Bone marrow transplantation in acute leukemias: antibody treatment for suppression of graft-versus-host disease (author's transl)].
19810 citationsauthor #11
[Leukemic cell phenotypes and the lymphoid differentiation pathway (author's transl)].
19815 citationsauthor #3
Antileukemic, autologous bone marrow transplantation in childhood acute lymphoblastic leukemia.
19819 citationsauthor #6
The concept of antileukemic, autologous bone marrow transplantation in acute lymphoblastic leukemia.
198015 citationsauthor #5
Fc-receptor-bearing cells in spleen of mice injected with cell-free ehrlich ascites fluid (EAF)
19800 citationsauthor #3
Antibody incubation of human marrow graft for prevention graft versus host disease
19803 citationsauthor #5

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT